Clinical Trial Detail

NCT ID NCT02499861
Title Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors St. Justine's Hospital
Indications

lymphoma

leukemia

Advanced Solid Tumor

Therapies

Decitabine + Genistein

Age Groups: adult child

No variant requirements are available.